RESEARCH-USE BIOSIMILAR ANTIBODY
Budigalimab
Monoclonal antibody · IgG1 kappa
Budigalimab is a chimeric biosimilar reference antibody directed against PDCD1/CD279/PD1.
TARGETPDCD1
YMonoclonal antibody
CATALOGSC-BS-696
CATALOG NUMBERSC-BS-696
MOLECULAR WEIGHTApprox. 146 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Budigalimab is a chimeric biosimilar reference antibody directed against PDCD1/CD279/PD1.
Budigalimab is a recombinant research-use antibody directed against PDCD1.